Eric Jonasch, MD, UT MD Anderson Cancer Center explains Axitinib Titration Post-I-O Therapy | Change Dose to Maximize Quality of Life at Annual Meeting 2018
Association Between Genomic Features | BAP1, SETD2, PBRM1, & VHL Mutations
Eric Jonasch, MD, UT MD Anderson Cancer Center explains Axitinib Titration Post-I-O Therapy | Change Dose to Maximize Quality of Life at Annual Meeting 2018